In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and ...

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

The regulatory clearance for Alembic Pharma's Gujarat facility came without any observations. The USFDA had inspected the ...

The global anti-osteoporosis therapy and fracture healing market is poised for remarkable growth, with projections indicating a rise from USD 14,051.6 million in 2023 to USD 22,427.6 million by 2033, ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Naqi Logix founder Dave Segal has invented a device that lets anyone control a computer with their head—no brain implant required.

New food hygiene ratings have been awarded to 18 of the Forest of Dean’s establishments, the Food Standards Agency’s website shows – and it’s good news for them all.

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...